HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

glucopyranosylamine

structure given in first source

Also Known As:

beta-D-glucopyranosylamine

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Carbohydrates: 22023
- Amino Sugars: 110
  - Hexosamines: 733
    - Glucosamine: 1771
      - glucopyranosylamine: 3

Experts

1.	Fischer, Thomas: 1 article (04/2019)
2.	Koulas, Symeon M: 1 article (04/2019)
3.	Kyriakis, Efthimios: 1 article (04/2019)
4.	Leonidas, Demetres D: 1 article (04/2019)
5.	Liggri, Panagiota G V: 1 article (04/2019)
6.	Riedl, Rainer: 1 article (04/2019)
7.	Skamnaki, Vassiliki T: 1 article (04/2019)
8.	Stravodimos, George A: 1 article (04/2019)
9.	Tsagkarakou, Anastasia S: 1 article (04/2019)
10.	Zographos, Spyros E: 1 article (04/2019)

Related Diseases

1.	Aspartylglucosaminuria 07/01/1974 - "The isolation and analysis of 2-acetamido-N-(4'-l-aspartyl)-2-deoxy-beta-d- glucopyranosylamine and 13 higher-molecular-weight derivatives from the urine of a patient with aspartylglycosaminuria is described. "
2.	Mucolipidoses (Sialidosis) 12/01/1982 - "Normal and mucolipidosis III urinary beta-N-acetyl-d-hexosaminidase A were purified to apparent homogeneity by using affinity [Sepharose-2-acetamido-N-(epsilon-aminocaproyl)-2-deoxy-beta- d-glucopyranosylamine] and ion-exchange (DEAE- and CM-cellulose) chromatography. "
3.	Type 2 Diabetes Mellitus (MODY) 04/03/2019 - "Structure-based design and synthesis of two biphenyl-N-acyl-β-d-glucopyranosylamine derivatives as well as their assessment as inhibitors of human liver glycogen phosphorylase (hlGPa, a pharmaceutical target for type 2 diabetes) is presented. "

Related Drugs and Biologics

1.	Sepharose (Agarose)
2.	Liver Glycogen
3.	Phosphorylases (Glucan Phosphorylase)
4.	Cellulose
5.	beta-N-Acetylhexosaminidases
6.	diphenyl (biphenyl)
7.	2-diethylaminoethanol (DEAE)